New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
07:32 EDTXOMAXOMA downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded XOMA following the Phase II trial failure of gevokizumab in Erosive Osteoarthritis of the Hand.
News For XOMA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
06:02 EDTXOMAStocks with implied volatility above IV index mean; YELP XOMA
Subscribe for More Information
June 29, 2015
05:51 EDTXOMAStocks with implied volatility movement; XOMA EXEL
Subscribe for More Information
June 26, 2015
09:41 EDTXOMAXOMA mentioned positively by Biotech Insider
06:05 EDTXOMAStocks with implied volatility above IV index mean; XOMA NBG
Subscribe for More Information
June 25, 2015
05:57 EDTXOMAStocks with implied volatility above IV index mean; XOMA YELP
Subscribe for More Information
June 24, 2015
05:57 EDTXOMAStocks with implied volatility above IV index mean; XOMA THC
Stocks with implied volatility above IV index mean; XOMA (XOMA) 169, Tenet (THC) 51 according to iVolatility.
June 23, 2015
05:57 EDTXOMAStocks with implied volatility above IV index mean; XOMA YELP
Subscribe for More Information
June 22, 2015
14:08 EDTXOMAXOMA calls active as shares rally
Subscribe for More Information
June 16, 2015
09:06 EDTXOMAXOMA receives ODD for XOMA 358 from FDA
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use